Generic Name and Formulations:
Dyphylline 200mg, 400mg; scored tabs.
Indications for LUFYLLIN:
For relief of acute bronchial asthma and for reversible bronchospasm associated with chronic bronchitis and emphysema.
Individualize. Usual dose: up to 15mg/kg every 6 hours. Renal impairment: adjust dose.
Not for primary treatment of acute attack. Severe cardiac disease. Hypertension. Hyperthyroidism. Acute myocardial injury. Peptic ulcer. Pregnancy (Cat.C). Nursing mothers.
Toxicity with concomitant sympathomimetics. Potentiated by probenecid.
GI upset, epigastric pain, hematemesis, headache, irritability, restlessness, insomnia, hyperexcitability, agitation, muscle twitching, generalized clonic and tonic convulsions, palpitation, tachycardia, extrasystoles, flushing, hypotension, circulatory failure, ventricular arrhythmias, tachypnea, gross and microscopic hematuria, diuresis, hyperglycemia, inappropriate ADH syndrome.
Endocrinology Advisor Articles
- Behavioral Weight Loss Interventions May Prevent Obesity
- PCSK9 Inhibition: Benefits Outweigh Risks in Patients With Diabetes
- Association Between Urine Complement Proteins and Kidney Disease, Mortality in T2D
- Rates of Incident Type 2 Diabetes in Chronic Kidney Disease
- Availability and Affordability of Diabetes Medication Worldwide
- Estradiol, Cortisol, TGF-β1 Involved in Thyroid Immunity During Pregnancy and Postpartum
- Pharmacotherapy Personalization May Optimize Outcomes for Type 2 Diabetes
- Late-Onset Epilepsy Linked to Diabetes
- Examining the Ethical Considerations of Grateful Patient Fundraising
- Muscle Cell Proﬁles Relate to Exercise Response Variation in Type 2 Diabetes